Journal: The Pediatric infectious disease journal

Article Title: Brain-Derived Neurotrophic Factor is Associated with Disease Severity and Clinical Outcome in Ugandan Children Admitted to Hospital with Severe Malaria.

PMID/MRN: 27798544

Publication Date: 2016-Oct-25

Abstract:

Malaria remains a leading cause of childhood death and neurological disability in sub-Saharan Africa. Here we test the hypothesis that malaria-induced alterations to circulating brain-derived neurotrophic factor (BDNF) are associated with poor clinical outcomes in children with severe malaria. We quantified BDNF (by ELISA) in plasma samples collected (at presentation [day1], day 3, and day 14), during a prospective study of Ugandan children admitted to hospital with severe malaria (n=179). BDNF concentration at presentation (day 1) was lower in children with cerebral malaria (P < 0.01), coma (P < 0.01), LambarŽnŽ Organ Dysfunction Score >1 (P < 0.05), and respiratory distress (P < 0.01). Higher BDNF concentration at presentation was associated with shorter time to coma recovery (HR = 1.655 (1.194, 2.293), P = 0.002) and a reduced odds ratio of disability (0.50 (0.27, 0.94), P = 0.047) and death (0.45 (0.22, 0.92), P = 0.035). BDNF concentration was lower on day 1 and increased in children surviving severe malaria (day 14; P < 0.0001). Our findings provide the new evidence linking circulating BDNF with disease severity, coma recovery and clinical outcome in children with severe malaria.